Drag

Zydus Lifesciences

Healthcare NSE:ZYDUSLIFE

902.40INR
-7.65 ( -0.84%)

Last update at Feb. 19, 2026, midnight

Day Range

900.30919.75
LowHigh

52 Week Range

786.00 1059.05
LowHigh

Fundamentals

  • Previous Close 910.05
  • Market Cap 931571.43M
  • Volume736,002
  • P/E Ratio 18.94
  • EBITDA 69382.00M
  • Revenue TTM 244939.00M
  • Revenue Per Share TTM 243.43
  • Gross Profit TTM 175330.00M
  • Diluted EPS TTM 48.88

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED ZYDUSLIFE ₹ 940.50 8/08/25 8/08/25 Same Day Short Term Healthcare 0.21%
CLOSED ZYDUSLIFE ₹ 890.95 21/05/25 2/06/25 11 Days Short Term Healthcare 5.00%
CLOSED ZYDUSLIFE ₹ 1126.50 28/08/24 28/08/24 Same Day Short Term Healthcare 1.02%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 60845.00M 49273.00M 25897.00M 28381.00M 22848.00M
Net income 45255.00M 38595.00M 19649.00M 44873.00M 21336.00M
Total Revenue 232415.00M 195474.00M 168778.00M 148276.00M 148215.00M
Gross Profit 167031.00M 131537.00M 105677.00M 90087.00M 93415.00M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 372017.00M 292808.00M 257564.00M 277954.00M 238847.00M
Intangible assets 32236.00M 26110.00M 10905.00M 11272.00M 12363.00M
Other current assets 7096.00M 11343.00M 7573.00M 48.00M 28.00M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 4138.00M -748.00M -5338.00M 23729.00M -905.00M
Operating Cash 67767.00M 31963.00M 26888.00M 21041.00M 32930.00M
Free Cash Flow 50641.00M 23213.00M 16579.00M 9015.00M 24390.00M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
NSE:ZYDUSLIFE
Zydus Lifesciences 		-7.65 -0.84% 902.40 931571.43 18.94
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-11.30 -0.66% 1713.10 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-4.00 -0.06% 6279.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		16.50 0.39% 4227.30 1362716.66 63.48
CIPLA
Cipla Limited 		-19.10 -1.42% 1330.70 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.